{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T10:20:27Z","timestamp":1786616427393,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40120-020-00215-2","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T07:02:47Z","timestamp":1603350167000},"page":"435-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunomagnetic Reduction Detects Plasma A\u03b21\u201342 Levels as a Potential Dominant Indicator Predicting Cognitive Decline"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7850-4597","authenticated-orcid":false,"given":"Shieh-Yueh","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"215_CR1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF00294259","volume":"89","author":"R Mena","year":"1995","unstructured":"Mena R, Edwards P, P\u00e9rez-Olvera O, Wischik CM. Monitoring pathological assembly of tau and \u03b2-amyloid proteins in Alzheimer's disease. Acta Neuropathol. 1995;89:50\u20136.","journal-title":"Acta Neuropathol"},{"key":"215_CR2","first-page":"417314","volume":"2010","author":"TH An","year":"2010","unstructured":"An TH, Termont A, Merchiers P, Schilling S, Demuth HU, Scrocchi L, et al. Pathological hallmarks, clinical parallels, and value for drug testing in Alzheimer\u2019s disease of the APP[V717I] London transgenic mouse model. Int J Alzheimer Dis. 2010;2010:417314.","journal-title":"Int J Alzheimer Dis."},{"key":"215_CR3","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/brain\/awv236","volume":"138","author":"J Braak","year":"2015","unstructured":"Braak J, Tredici KD. The preclinical phase of the pathological process underlying sporadic Alzheimer's disease. Brain. 2015;138:2814\u201333.","journal-title":"Brain"},{"key":"215_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-\u03b2 plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29\u201338.","journal-title":"Nat Med"},{"key":"215_CR5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrneurol.2009.217","volume":"6","author":"A Nordberg","year":"2010","unstructured":"Nordberg A, Rinn JO, Kadir A, L\u00e5ngstr\u00f6m B. The use of PET in Alzheimer disease. Nature Rev Neurol. 2010;6:78\u2013877.","journal-title":"Nature Rev Neurol"},{"key":"215_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fnins.2014.00327","volume":"8","author":"PA Adlard","year":"2014","unstructured":"Adlard PA, Tran BA, Finkelstein DI, Desmond PM, Johnston LA, Bush AI, et al. A review of \u03b2-amyloid neuroimaging in Alzheimer\u2019s disease. Front Neurosci. 2014;8:327.","journal-title":"Front Neurosci"},{"key":"215_CR7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016;79:110\u20139.","journal-title":"Ann Neurol"},{"key":"215_CR8","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack","year":"2018","unstructured":"Jack CR, Wiste HJ, Schwarz CG, Lowe VL, Senjem ML, Vemuri P, et al. Longitudinal tau PET in ageing and Alzheimer\u2019s disease. Brain. 2018;141:1517\u201328.","journal-title":"Brain"},{"key":"215_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2796.2004.01381.x","volume":"256","author":"MJ de Leon","year":"2004","unstructured":"de Leon MJ, Desanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, et al. MRI and CSF studies in the early diagnosis of Alzheimer\u2019s disease. J Int Med. 2004;256:205\u201323.","journal-title":"J Int Med"},{"key":"215_CR10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awl063","volume":"129","author":"M Bibl","year":"2006","unstructured":"Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki HW, Sparbier K, et al. CSF amyloid-\u03b2-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain. 2006;129:1177\u201387.","journal-title":"Brain"},{"key":"215_CR11","first-page":"606802","volume":"2010","author":"A Anoop","year":"2010","unstructured":"Anoop A, Singh PK, Jacob RS, Maji SK. CSF biomarkers for Alzheimer\u2019s disease diagnosis. Int J Alzheimer\u2019s Dis. 2010;2010:606802\u201312.","journal-title":"Int J Alzheimer\u2019s Dis"},{"key":"215_CR12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4236\/aad.2012.13005","volume":"1","author":"R Agarwal","year":"2012","unstructured":"Agarwal R, Chhillar N, Mishra VN, Tripathi CB. CSF tau and amyloid \u03b242 levels in Alzheimer\u2019s disease\u2014a meta-analysis. Adv Alzheimer\u2019s Dis. 2012;1:30\u201344.","journal-title":"Adv Alzheimer\u2019s Dis"},{"key":"215_CR13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15:673\u201384.","journal-title":"Lancet Neurol"},{"key":"215_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2017.06.002","volume":"58","author":"JB Pereira","year":"2017","unstructured":"Pereira JB, Westman E, Hansson O, ADNI. Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer\u2019s disease. Neurobiol Aging. 2017;58:14\u201329.","journal-title":"Neurobiol Aging"},{"key":"215_CR15","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3233\/JAD-170784","volume":"62","author":"CE Teunissen","year":"2018","unstructured":"Teunissen CE, Chiu MJ, Yang CC, Yang SY, Scheltens P, Zetterberg H, et al. Plasma amyloid-\u03b2 (A\u03b242) correlates with cerebrospinal fluid A\u03b242 in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;62:1857\u201363.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"215_CR16","first-page":"190","volume":"66","author":"W Xia","year":"2009","unstructured":"Xia W, Yang T, Shankar G, Smith IM, Shen Y, Walsh DM, et al. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch Neurol. 2009;66:190\u20139.","journal-title":"Arch Neurol"},{"key":"215_CR17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JAD-2010-100456","volume":"21","author":"ES Oh","year":"2010","unstructured":"Oh ES, Mielke MM, Rosenberg PB, Jain A, Fedarko NS, Lyketsos CG, et al. Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-\u03b2 in plasma. J Alzheimer\u2019s Dis. 2010;21:769\u201373.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"215_CR18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.vetmic.2007.04.001","volume":"123","author":"E Birkmann","year":"2007","unstructured":"Birkmann E, Henke F, Weinmann N, Dumpitak C, Groschup M, Funke A, et al. Counting of single prion particles bound to a capture-antibody surface (surface-FIDA). Vet Microbiol. 2007;123:294\u2013304.","journal-title":"Vet Microbiol"},{"key":"215_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2014.06.024","volume":"840","author":"JS Kim","year":"2014","unstructured":"Kim JS, Ahn HS, Cho SM, Lee JE, Kim YS, Lee C. Detection and quantification of plasma amyloid-\u03b2 by selected reaction monitoring mass spectrometry. Anal Chim Acta. 2014;840:1\u20139.","journal-title":"Anal Chim Acta"},{"key":"215_CR20","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1038\/srep06446","volume":"4","author":"S Mondello","year":"2014","unstructured":"Mondello S, Buki A, Barzo P, Randall J, Provuncher G, Hanlon D, et al. CSF and plasma amyloid-\u03b2 temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury. Sci Rep. 2014;4:6446\u2013511.","journal-title":"Sci Rep"},{"key":"215_CR21","doi-asserted-by":"crossref","first-page":"014703","DOI":"10.1063\/1.2827359","volume":"103","author":"JJ Chieh","year":"2008","unstructured":"Chieh JJ, Yang SY, Jian ZF, Wang WC, Horng HE, Yang HC, et al. Hyper-high-sensitivity wash-free magnetoreduction assay on biomolecules using high-Tc superconducting quantum interference devices. J Appl Phys. 2008;103:014703.","journal-title":"J Appl Phys"},{"key":"215_CR22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1109\/TASC.2010.2087304","volume":"21","author":"MJ Chiu","year":"2011","unstructured":"Chiu MJ, Horng HE, Chieh JJ, Liao SH, Chen CH, Shih BY, et al. Multi-channel SQUID-based ultra-high-sensitivity in-vitro detections for bio-markers of Alzheimer\u2019s disease via immunomagnetic reduction. IEEE Trans Appl Supercond. 2011;21:477\u201380.","journal-title":"IEEE Trans Appl Supercond"},{"key":"215_CR23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/cn500101j","volume":"5","author":"KY Tzen","year":"2014","unstructured":"Tzen KY, Yang SY, Chen TF, Cheng TW, Horng HE, Wen HP, et al. Plasma A\u03b2 but not tau is related to brain PiB retention in early Alzheimer\u2019s disease. ACS Chem Neurosci. 2014;5:830\u20136.","journal-title":"ACS Chem Neurosci"},{"key":"215_CR24","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/hbm.22390","volume":"35","author":"MJ Chiu","year":"2014","unstructured":"Chiu MJ, Chen YF, Chen TF, Yang SY, Yang FPG, Tseng TW, et al. Plasma tau as a window to the brain\u2014negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer\u2019s disease. Hum Brain Mapp. 2014;35:3132\u201342.","journal-title":"Hum Brain Mapp"},{"key":"215_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13195-019-0566-0","volume":"11","author":"SY Lin","year":"2019","unstructured":"Lin SY, Lin KJ, Lin PC, Huang CC, Chang CH, Lee YC, et al. Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2019;11:111.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"215_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fnagi.2018.00175","volume":"10","author":"LY Fan","year":"2018","unstructured":"Fan LY, Tzen KY, Chen YF, Chen TF, Lai YM, Yen RF, et al. The relation between brain amyloid deposition, cortical atrophy, and plasma biomarkers in amnesic mild cognitive impairment and Alzheimer\u2019s disease. Front Aging Neurosci. 2018;10:175.","journal-title":"Front Aging Neurosci"},{"key":"215_CR27","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2174\/156720512804142967","volume":"9","author":"MJ Chiu","year":"2012","unstructured":"Chiu MJ, Yang SY, Chen TF, Chieh JJ, Huang TZ, Yip PK, et al. New assay for old markers-plasma beta amyloid of mild cognitive impairment and Alzheimer\u2019s disease. Curr Alzheimer\u2019s Res. 2012;9:1142\u20138.","journal-title":"Curr Alzheimer\u2019s Res"},{"key":"215_CR28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fnagi.2017.00226","volume":"9","author":"LF Lue","year":"2017","unstructured":"Lue LF, Sabbagh MN, Chiu MJ, Jing N, Snyder NL, Schmitz C, et al. Plasma levels of A\u03b242 and tau identified probable Alzheimer\u2019s dementia: findings in two cohorts. Front Aging Neurosci. 2017;9:226.","journal-title":"Front Aging Neurosci"},{"key":"215_CR29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3233\/JAD-170810","volume":"61","author":"CC Yang","year":"2018","unstructured":"Yang CC, Chiu MJ, Chen TF, Chang HL, Liu BH, Yang SY. Assay of plasma phosphorylated tau protein (Threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;61:1323\u201332.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"215_CR30","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/s40120-017-0075-7","volume":"6","author":"SY Yang","year":"2017","unstructured":"Yang SY, Chiu MJ, Chen TF, Horng HE. Detection of plasma biomarkers using immunomagnetic reduction: a promising method for the early diagnosis of Alzheimer\u2019s disease. Neurol Ther. 2017;6:S37\u2013S45.","journal-title":"Neurol Ther"},{"key":"215_CR31","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1007\/s40120-019-00167-2","volume":"8","author":"LF Lue","year":"2019","unstructured":"Lue LF, Kuo YM, Sabbagh MN. Advance in plasma AD core biomarker development: current findings from immunomagnetic reduction-based SQUID technology. Neurol Ther. 2019;8:S95\u2013S111.","journal-title":"Neurol Ther"},{"key":"215_CR32","first-page":"316","volume":"8","author":"NC Lee","year":"2017","unstructured":"Lee NC, Yang SY, Chieh JJ, Huang PS, Chang LM, Chiu YN, et al. Blood beta-amyloid and Tau in Down Syndrome: a comparison with Alzheimer\u2019s disease. Front Aging Neurosci. 2017;8:316.","journal-title":"Front Aging Neurosci"},{"key":"215_CR33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s12017-018-8513-y","volume":"20","author":"SC Tang","year":"2018","unstructured":"Tang SC, Yang KC, Chen CH, Yang SY, Chiu MJ, Wu CC, et al. Plasma \u03b2-amyloids and tau proteins in patients with vascular cognitive impairment. Neuro Mol Med. 2018;20:498\u2013503.","journal-title":"Neuro Mol Med"},{"key":"215_CR34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3389\/fneur.2019.00715","volume":"10","author":"NF Chi","year":"2019","unstructured":"Chi NF, Chao SP, Huang LK, Chan L, Chen YR, Chiou HY, et al. Plasma amyloid beta and tau levels are predictors of post-stroke cognitive impairment: a longitudinal study. Front Neurol. 2019;10:715.","journal-title":"Front Neurol."},{"key":"215_CR35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpsychires.2020.06.006","volume":"129","author":"CL Tsai","year":"2020","unstructured":"Tsai CL, Liang CS, Yang CP, Lee JT, Ho TH, Su MW, et al. Indicators of rapid cognitive decline in amnestic mild cognitive impairment: the role of plasma biomarkers using magnetically labeled immunoassays private. J Psychiatry Res. 2020;129:66\u201372.","journal-title":"J Psychiatry Res."},{"key":"215_CR36","first-page":"158","volume":"32","author":"SJ Lin","year":"1991","unstructured":"Lin SJ, Hu SC, Sheu SF, Ho JW, Chiou PC, Chao MC, et al. [Anthropometric study on Down syndrome in Taiwan] Zhonghua Min. Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1991;32:158\u201364.","journal-title":"Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"215_CR37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1352\/0895-8017(2004)109<83:RFFDIP>2.0.CO;2","volume":"109","author":"A Bush","year":"2014","unstructured":"Bush A, Beail N. Risk factors for dementia in people with Down syndrome: issues in assessment and diagnosis. Am J Ment Retard. 2014;109:83\u201397.","journal-title":"Am J Ment Retard"},{"key":"215_CR38","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1161\/STROKEAHA.114.004285","volume":"45","author":"SN Whitehead","year":"2014","unstructured":"Whitehead SN, Thiel A, Cechetto DF, Heiss WD, Hachinski V, Whitehead SN. Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke. Stroke. 2014;45:2825\u20139.","journal-title":"Stroke"},{"key":"215_CR39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00004647-200003000-00013","volume":"20","author":"C Mailliot","year":"2000","unstructured":"Mailliot C, Podevin-Dimster V, Rosenthal RE, Sergeant N, Delacourte A, Fiskum G, et al. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion. J Cereb Blood Flow Metab. 2000;20:543\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"215_CR40","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/STROKEAHA.113.004534","volume":"45","author":"GA Rosenberg","year":"2014","unstructured":"Rosenberg GA, Bjerke M, Wallin A. Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment. Stroke. 2014;45:1531\u20138.","journal-title":"Stroke"},{"key":"215_CR41","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","volume":"8","author":"ST Pendlebury","year":"2009","unstructured":"Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8:1006\u2013188.","journal-title":"Lancet Neurol"},{"key":"215_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","volume":"15","author":"MD Mijajlovi\u0107","year":"2017","unstructured":"Mijajlovi\u0107 MD, Pavlovi\u0107 A, Brainin M, Heiss W-D, Quinn TJ, Ihle-Hansen HB, et al. Post-stroke dementia\u2014a comprehensive review. BMC Med. 2017;15:11.","journal-title":"BMC Med"},{"key":"215_CR43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jpsychores.2014.08.009","volume":"77","author":"TB Cumming","year":"2014","unstructured":"Cumming TB, Brodtmann A, Darby D, Bernhardt J. The importance of cognition to quality of life after stroke. J Psychosom Res. 2014;77:374\u20139.","journal-title":"J Psychosom Res"},{"key":"215_CR44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1532-5415.2005.53019.x","volume":"53","author":"S Stephens","year":"2005","unstructured":"Stephens S, Kenny RA, Rowan E, Kalaria RN, Bradbury M, Pearce R, et al. Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia. J Am Geriatr Soc. 2005;53:103\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"215_CR45","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4103\/0028-3886.271245","volume":"67","author":"M Tripathi","year":"2019","unstructured":"Tripathi M, Parida GK, Kumar R, Dwivedi S, Nehra A, Bal C. Biomarker-based prediction of progression to dementia: F-18 FDG-PET in amnestic MCI. Neurol India. 2019;67:1310\u20137.","journal-title":"Neurol India"},{"key":"215_CR46","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3233\/JAD-170507","volume":"60","author":"H Jang","year":"2017","unstructured":"Jang H, Ye BS, Woo S, Kim SW, Chin J, Choi SH, et al. Prediction model of conversion to dementia risk in subjects with amnestic mild cognitive impairment: a longitudinal, multi-center clinic-based study. J Alzheimer\u2019s Dis. 2017;60:1579\u201387.","journal-title":"J Alzheimer\u2019s Dis"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-020-00215-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T23:47:39Z","timestamp":1634860059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-020-00215-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s40120-020-00215-2","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"6 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}